Inhalation Diagnostic Agent

37 marketed 4 in Phase 3

This page covers all Inhalation Diagnostic Agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium-dependent dopamine transporter, Amyloid beta A4 protein, somatostatin receptors, particularly SSTR2.

Targets

Sodium-dependent dopamine transporter · Amyloid beta A4 protein · somatostatin receptors, particularly SSTR2 · Glutamate carboxypeptidase 2 · High affinity choline transporter 1 · Estrogen receptor · glucose transporter proteins, hexokinase, glucose-6-phosphatase · Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase · PSMA · Dopamine transporter (DaT)

Marketed (37)

Phase 3 pipeline (4)

Patent intelligence